PROGRESSIS VACCINE PRRS VIRUS
PROGRESSIS VACCINE PRRS VIRUS
Authorised
- Porcine reproductive and respiratory syndrome virus, type 1, strain PRRS 94881, Live
Product identification
Medicine name:
PROGRESSIS VACCINE PRRS VIRUS
PROGRESSIS Ενέσιμο γαλάκτωμα για χοίρους (σύες και νεαρά θηλυκά ζώα αναπαραγωγής)
Active substance:
- Porcine reproductive and respiratory syndrome virus, type 1, strain PRRS 94881, Live
Target species:
-
Pig
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Porcine reproductive and respiratory syndrome virus, type 1, strain PRRS 94881, Live2.50/log10 fluorescent assay infectious dose 50%2.00millilitre(s)
Pharmaceutical form:
-
Emulsion for suspension for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Pig
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI09AA05
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Cyprus
Package description:
- Available only in Greek
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
- MERIAL, Laboratory of Lyon Gerland
Responsible authority:
- Veterinary Services, Ministry Of Agriculture, Natural Resources And Environment
Authorisation number:
- CY00011V
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Greek (PDF)
Published on: 26/08/2022
How useful was this page?:
